Literature DB >> 2036082

Ulcerative colitis--what is the risk of developing colorectal cancer?

G Whelan1.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 2036082     DOI: 10.1111/j.1445-5994.1991.tb03008.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


× No keyword cloud information.
  5 in total

1.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Adiponectin deficiency: role in chronic inflammation induced colon cancer.

Authors:  Arpit Saxena; Alexander Chumanevich; Emma Fletcher; Bianca Larsen; Kirby Lattwein; Kamaljeet Kaur; Raja Fayad
Journal:  Biochim Biophys Acta       Date:  2011-12-16

3.  Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study.

Authors:  D Kornfeld; A Ekbom; T Ihre
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

Review 4.  Inflammatory bowel disease cause-specific mortality: a primer for clinicians.

Authors:  Zain Kassam; Sara Belga; Idan Roifman; Simon Hirota; Humberto Jijon; Gilaad G Kaplan; Subrata Ghosh; Paul L Beck
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

5.  3-(1H-Benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1,2,4-oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells against Oxidative Stress via ERK1/2 Phosphorylation.

Authors:  Li-Li Xu; Tian Liu; Lei Wang; Li Li; Yu-Feng Wu; Cui-Cui Li; Bin Di; Qi-Dong You; Zheng-Yu Jiang
Journal:  Oxid Med Cell Longev       Date:  2018-05-20       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.